Tag:
AM-Pharma
Latest Headlines
Latest Headlines
AM-Pharma snares $42M venture round for kidney injury trials
Dutch biotech AM-Pharma has scooped up a $42 million venture round designed to push a preclinical alkaline phosphatase program for acute kidney injury through a mid-stage study. And it picked up some
